X-136149229-T-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001159702.3(FHL1):c.-101+1601T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001159702.3 intron
Scores
Clinical Significance
Conservation
Publications
- X-linked myopathy with postural muscle atrophyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- myopathy, reducing body, X-linked, early-onset, severeInheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- reducing body myopathyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked Emery-Dreifuss muscular dystrophyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked scapuloperoneal muscular dystrophyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001159702.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FHL1 | TSL:5 MANE Plus Clinical | c.-101+1601T>G | intron | N/A | ENSP00000377710.2 | Q13642-2 | |||
| FHL1 | c.-243+1351T>G | intron | N/A | ENSP00000498684.1 | Q13642-2 | ||||
| FHL1 | TSL:2 | c.-101+2217T>G | intron | N/A | ENSP00000486439.1 | Q13642-1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 genome Cov.: 23
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at